The Federal Trade Commission has reached a landmark settlement with Express Scripts, addressing allegations that the pharmacy benefit manager inflated drug prices, including for insulin, to boost ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts, banning practices that inflated drug list prices and limited access to cheaper medications. The agreement is ...

Cerner is partnering with Surescripts to implement a prescription price transparency tool into its Millennium electronic ...

If you fill prescriptions through Tricare and noticed that your costs went up in January, you were not imagining it. The fiscal 2018 National Defense Authorization Act set in motion a schedule of ...

MONTREAL and CHARLOTTE, N.C., March 31, 2026 (GLOBE NEWSWIRE)-- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of ...

The Federal Trade Commission’s Feb.4 consent order with Express Scripts represents the most consequential structural overhaul of the pharmacy benefit manager industry to date. Policymakers and ...

On February 4, 2026, the Federal Trade Commission (FTC) proposed to settle its enforcement action against leading pharmacy benefit manager (PBM) Express Scripts, going beyond the insulin products that ...

The MarketWatch News Department was not involved in the creation of this content. Nation's largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates ...

A Chicago plumbers’ union is accusing Express Scripts Inc. of giving certain drugmakers preferential patient access in exchange for billions of dollars in rebates it withheld from the union health ...

Nation’s largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates from PBM customers. Today, Bernstein Litowitz Berger & Grossmann LLP (BLB&G) ...

On February 4, 2026, Express Scripts agreed to a settlement with the Federal Trade Commission (FTC) in the agency’s administrative case against the nation’s three largest pharmacy benefit managers ...